Syndecan 4 regulation of the development of autoimmune arthritis in mice by modulating B cell migration and germinal center formation

Arthritis and Rheumatology

Volumn 67, Issue 9, 2015, Pages 2512-2522

  Endo, Tsutomu ^a   Ito, Koyu ^b   Morimoto, Junko ^b   Kanayama, Masashi ^b   Ota, Daichi ^b   Ikesue, Masahiro ^b   Kon, Shigeyuki ^b   Takahashi, Daisuke ^a   Onodera, Tomohiro ^a   Iwasaki, Norimasa ^a   Uede, Toshimitsu ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 4; COLLAGEN TYPE 2; CXCL12 PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; SDC4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; ANIMAL; CELL MOTION; EXPERIMENTAL ARTHRITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CXCL12; COLLAGEN TYPE II; GERMINAL CENTER; IMMUNITY, HUMORAL; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SYNDECAN-4; T-LYMPHOCYTES;

EID: 84940118564     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39193     Document Type: Article

References (37)

1. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al., for the REFLEX Trial Group. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006; 54: 2793-806.
2. Weyand CM, Goronzy JJ., Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003; 987: 140-9.
3. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
4. Mullazehi M, Wick MC, Klareskog L, van Vollenhoven R, Ronnelid J., Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis. Arthritis Res Ther 2012; 14: R100.
5. Vinuesa CG, Sanz I, Cook MC., Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009; 9: 845-57.
6. Vinuesa CG, Cyster JG., How T cells earn the follicular rite of passage. Immunity 2011; 35: 671-80.
7. Coelho FM, Natale D, Soriano SF, Hons M, Swoger J, Mayer J, et al., Naive B-cell trafficking is shaped by local chemokine availability and LFA-1-independent stromal interactions. Blood 2013; 121: 4101-9.
8. Wang X, Cho B, Suzuki K, Xu Y, Green JA, An J, et al., Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med 2011; 208: 2497-510.
9. Hauser AE, Junt T, Mempel TR, Sneddon MW, Kleinstein SH, Henrickson SE, et al., Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity 2007; 26: 655-67.
10. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S., Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000; 64: 323-32.
11. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR, et al., Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002; 196: 65-75.
12. Kaneider NC, Feistritzer C, Gritti D, Mosheimer BA, Ricevuti G, Patsch JR, et al., Expression and function of syndecan-4 in human platelets. Thromb Haemost 2005; 93: 1120-7.
13. Yamashita Y, Oritani K, Miyoshi EK, Wall R, Bernfield M, Kincade PW., Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J Immunol 1999; 162: 5940-8.
14. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Iwase M, Yoshikai Y, et al., Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem 2001; 276: 47483-8.
15. 9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol 2009; 182: 8015-25.
16. 1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation. J Immunol 2011; 187: 5851-64.
17. Cho YG, Cho ML, Min SY, Kim HY., Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007; 7: 65-70.
18. Pan M, Kang I, Craft J, Yin Z., Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J Clin Immunol 2004; 24: 481-91.
19. Pohlers D, Nissler K, Frey O, Simon J, Petrow PK, Kinne RW, et al., Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol 2004; 135: 409-15.
20. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R., Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004; 6: R544-50.
21. Tanaka D, Kagari T, Doi H, Shimozato T., Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 2006; 119: 195-202.
22. Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St Clair EW, Tedder TF., B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007; 179: 1369-80.
23. Stuart JM, Dixon FJ., Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983; 158: 378-92.
24. Leavenworth JW, Wang X, Wenander CS, Spee P, Cantor H., Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci U S A 2011; 108: 14584-9.
25. Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C, et al., Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/CXCL12. FEBS J 2005; 272: 1937-51.
26. Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X, et al., Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1α/CXCR4-mediated migration of epithelioid carcinoma cells. Mol Cancer Res 2005; 3: 227-36.
27. Vicente-Manzanares M, Rey M, Jones DR, Sancho D, Mellado M, Rodriguez-Frade JM, et al., Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1α-induced lymphocyte polarization and chemotaxis. J Immunol 1999; 163: 4001-12.
28. Bao X, Moseman EA, Saito H, Petryniak B, Thiriot A, Hatakeyama S, et al., Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity 2010; 33: 817-29.
29. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al., Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-81.
30. Svensson L, Jirholt J, Holmdahl R, Jansson L., B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111: 521-6.
31. Afzali B, Lombardi G, Lechler RI, Lord GM., The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
32. Leavenworth JW, Tang X, Kim HJ, Wang X, Cantor H., Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells. J Clin Invest 2013; 123: 1382-9.
33. Crotty S., Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29: 621-63.
34. Vinuesa CG, Tangye SG, Moser B, Mackay CR., Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 2005; 5: 853-65.
35. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, et al., Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5: 943-52.
36. Allen CD, Okada T, Cyster JG., Germinal-center organization and cellular dynamics. Immunity 2007; 27: 190-202.
37. Hamon M, Mbemba E, Charnaux N, Slimani H, Brule S, Saffar L, et al., A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology 2004; 14: 311-23.